NEWSROOM
Perspectives on IP strategy, portfolio development, and the factors that shape how patents perform in practice.
DESIGNING MARKET LIFE: MAPPING PATENT AND REGULATORY EXCLUSIVITY FOR YOUR ASSET
Once you understand patent terms and regulatory exclusivity, the next step is designing a protection timeline for your product. This article shows how to combine US and EU rules, the EU Pharma Package, and development choices into a practical exclusivity map for your asset.
AI-ASSISTED DRUG DISCOVERY PATENTS: FROM ALGORITHM TO ASSET
AI can accelerate discovery, but it can’t be the inventor. This guide explains how inventorship works in AI-assisted drug discovery, what can go wrong in real workflows, and how in-house teams can document human decision-making to protect patent enforceability and deal readiness.